This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): EP2006, filgrastim (Neupogen) biosimilar, Zarzio (EU)
Description: Zarzio is a biosimilar of Amgen's approved drug, Neupogen (filgrastim). Filgrastim, like natural G-CSF, stimulates the production of the infection fighting white blood cells called neutrophils.
Additional information available to subscribers only: